Rating History for NephroGenex, Inc. (NIRX) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/11/2022 Terence Flynn New Coverage Equalweight
(N/A)
11.00
(N/A)
8.26
(8.26)
0% Details